Lee Jun Hee, Kim Sang Gyun, Cho Soo-Jeong
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
J Gastric Cancer. 2024 Apr;24(2):199-209. doi: 10.5230/jgc.2024.24.e15.
Long-term outcomes of patients with positive lateral margins (pLMs) after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). This study aimed to evaluate the remnant cancer and survival rates of patients with pLMs compared with those who underwent curative resection.
A retrospective analysis was performed on consecutive patients with pLMs as the only non-curative factor of expanded indication who underwent ESD for EGC with a follow-up duration of 5 years or more. The rates of remnant cancer, recurrence, and survival were analyzed and compared to those of control patients who underwent curative resection by propensity score matching.
Among 3,515 patients treated with ESD between 2005 and 2018, 123 non-curative EGCs were retrospectively analyzed. A total of 108 patients were followed up without endoscopic or surgical resection for 8.2 years. The control group was matched in a 1:1 ratio with patients with EGC who underwent curative resection after ESD. The observation group with pLMs had a higher incidence of remnant cancer (25.9%; 28/108) compared to that in the curative resection group (0/108; P=0.000). The remaining tumors were treated with surgical or endoscopic resection, and no additional recurrences were observed. The overall survival analysis demonstrated no significant difference between the observation and curative resection groups (P=0.577).
No difference was observed in the overall survival rate between observation and curative resection groups. Therefore, observation may be a possible option for incomplete ESD with pLMs if continuous follow-up is performed.
探讨早期胃癌(EGC)内镜黏膜下剥离术(ESD)后切缘阳性(pLMs)患者的长期预后。本研究旨在评估pLMs患者与接受根治性切除术患者的残余癌及生存率。
对连续接受ESD治疗的EGC患者进行回顾性分析,这些患者以pLMs作为扩大适应证的唯一非根治性因素,随访时间为5年或更长。分析残余癌、复发和生存率,并通过倾向评分匹配与接受根治性切除术的对照患者进行比较。
在2005年至2018年间接受ESD治疗的3515例患者中,对123例非根治性EGC进行了回顾性分析。共有108例患者未接受内镜或手术切除,随访8.2年。对照组与ESD后接受根治性切除的EGC患者按1:1比例匹配。pLMs观察组的残余癌发生率(25.9%;28/108)高于根治性切除组(0/108;P=0.000)。其余肿瘤采用手术或内镜切除治疗,未观察到额外复发。总生存分析显示观察组与根治性切除组之间无显著差异(P=0.577)。
观察组与根治性切除组的总生存率无差异。因此,如果进行持续随访,观察可能是pLMs不完全ESD的一种可行选择。